Gene: SLC34A3
Official Full Name: solute carrier family 34 member 3provided by HGNC
Gene Summary: This gene encodes a member of SLC34A transporter family of proteins, and is expressed primarily in the kidney. It is involved in transporting phosphate into cells via sodium cotransport in the renal brush border membrane, and contributes to the maintenance of inorganic phosphate concentration in the kidney. Mutations in this gene are associated with hereditary hypophosphatemic rickets with hypercalciuria. Alternatively spliced transcript variants varying in the 5' UTR have been found for this gene.[provided by RefSeq, Apr 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01705 | SLC34A3 Knockout cell line (HeLa) | Human | SLC34A3 | 1:3~1:6 | Negative | Online Inquiry |
SLC34A3 Gene Knockout Cell Lines are a specialized tool derived from various cell types designed to facilitate the detailed study of the SLC34A3 gene, which encodes the sodium-dependent phosphate transporter protein. By employing CRISPR-Cas9 gene editing technology, these cell lines have been engineered to completely disrupt the SLC34A3 gene, allowing researchers to investigate the biological, physiological, and pathological processes associated with phosphate metabolism and homeostasis.
The primary function of SLC34A3 gene knockout cell lines revolves around their ability to mimic genetic conditions leading to altered phosphate levels in cellular systems. By studying these cell lines, scientists can elucidate the roles of phosphate transport in renal function, bone metabolism, and even potential links to diseases such as chronic kidney disease and osteomalacia. The mechanisms underlying these processes can be assessed through various assays, including ion transport studies and cellular signaling pathways, providing insight inaccessible through standard wild-type models.
In scientific research and clinical applications, SLC34A3 gene knockout cell lines serve as invaluable assets for drug discovery, toxicology studies, and gene therapy approaches. The specificity of knockout models allows for the identification of gene function without interference from compensatory pathways typical in heterozygous models. Moreover, these cell lines can support the development of therapies targeting phosphate-related disorders, a growing area of interest in metabolic research.
A significant advantage of using SLC34A3 gene knockout cell lines over alternative models, such as wild-type cell lines or less targeted knockout approaches, lies in their superior ability to replicate the consequences of complete gene disruption. This specificity enhances experimental reproducibility and reliability, proving crucial for generating data that influences therapeutic strategies.
For researchers and clinicians focused on the intricate pathways of phosphate regulation and its implications in health and disease, SLC34A3 gene knockout cell lines offer a robust platform for study. With our extensive expertise in cellular engineering and commitment to providing high-quality biological products, we are dedicated to supporting scientific advancements in this pivotal area of research. Our commitment ensures that users gain access to reliable, reproducible, and scientifically rigorous tools necessary for cutting-edge research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.